| Literature DB >> 29721504 |
Hélio José Coelho-Júnior1, Ivan de Oliveira Gonçalvez2, Iris Callado Sanches3, Leandro Gonçalves3, Erico Chagas Caperuto3, Marco Carlos Uchida2, Bruno Rodrigues1.
Abstract
The present study aimed to investigate the impact of a 6-month multicomponent exercise program (MCEP) on physical function, cognition, and hemodynamic parameters of elderly normotensive (NTS) and hypertensive (HTS) osteoarthritis patients. A total of 99 elderly osteoarthritis patients (44 NTS and 55 HTS) were recruited and submitted to functional, cognitive, and hemodynamic evaluations before and after six months of a MCEP. The program of exercise was performed twice a week at moderate intensity. The physical exercises aggregated functional and walking exercises. Results indicate that 6 months of MCEP were able to improve one-leg stand and mobility (walking speeds) of osteoarthritis patients regardless of hypertension. On the other hand, cognitive and hemodynamic parameters were not altered after the MCEP. The findings of the present study demonstrate that 6 months of MCEP were able to improve the physical functioning (i.e., usual and maximal walking speed and balance) of osteoarthritis patients regardless of hypertensive condition.Entities:
Mesh:
Year: 2018 PMID: 29721504 PMCID: PMC5867618 DOI: 10.1155/2018/3714739
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1The experimental design used in the present study.
Comparison between the groups regarding the morphological and hemodynamic parameters.
| Variables | NTS-OA ( | HTS-OA ( |
|---|---|---|
|
| ||
| Age (years) | 63.9 ± 3.7 (60–71) | 68.4 ± 6.4 (60–85) |
| Weight (kg) | 66.6 ± 11.8 (48.1–89.8) | 73.7 ± 14.1 (44–109) |
| Height (cm) | 154.5 ± 2.5 (1.5–1.9) | 160.1 ± 6.0 (1.4–1.7) |
| BMI (kg/m2) | 26.6 ± 4.3 (16.6–39.7) | 28.8 ± 5.7 (20.3–43.4) |
| WC (cm) | 92.5 ± 12.4 (63–124) | 100.5 ± 13.3 (72–133) |
| HC (cm) | 102.5 ± 8.1 (88–120) | 107.6 ± 12.1 (89–141) |
| NC (cm) | 35.4 ± 2.9 (30–45) | 36.8 ± 3.2 (30–44) |
| Knee OA (%) | 5.3 | 18.2 |
| Hip OA (%) | 68.2 | 69.1 |
| Knee and hip OA (%) | 40.0 | 20.0 |
| Female (%) | 92.3 | 90.9 |
| Mean of medication | — | 1.4 ± 1.4 |
|
| ||
| Diuretic | — | 69.1 |
| Beta-blocker | — | 34.5 |
| ANG-II receptor antagonist | — | 16.4 |
| ACE inhibitor | — | 9.1 |
| Calcium channel blockers | — | 3.6 |
|
| ||
| SBP (mmHg) | 127.6 ± 14.6 (96–162) | 135.6 ± 18.2 (99–181) |
| DBP (mmHg) | 76.3 ± 9.7 (58–97) | 76.8 ± 11.9 (58–109) |
| MAP (mmHg) | 89.2 ± 21.9 (73–114) | 94.7 ± 17.7 (78–123) |
| HR (bpm) | 79.3 ± 10.0 (53–108) | 74.2 ± 11.3 (35–113) |
| DP (mmHg·bpm) | 9693 ± 2906 (6625–17496) | 9930 ± 2587 (4270–14238) |
| PP (mmHg) | 48.9 ± 16.7 (18–79) | 57.6 ± 17.8 (30–97) |
Data are presented as mean ± SD (min–max). NTS: normotensive; HTS: hypertensive; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; HR: heart rate; DP: double product; PP: pulse pressure; P < 0.05 versus NG; ANG: angiotensin; ACE: angiotensin-converting enzyme.
Effect of MEP on anthropometric parameters.
| Variable | NTS-OA | HTS-OA |
|---|---|---|
| Body mass (kg) | ||
| Pre | 66.6 ± 11.8 (48.1–89.8) | 73.7 ± 14.1 (44–109) |
| Post | 65.3 ± 11.9 (49–106.6) | 74.9 ± 13.9 (44–105) |
| Δ (%) | −0.79 | 6.51 |
| ES | 0.10 (trivial) | −0.08 (trivial) |
| Height (cm) | ||
| Pre | 154.5 ± 2.5 (1.5–1.9) | 160.1 ± 6.0 (1.4–1.7) |
| Post | 153.5 ± 5.8 (1.4–1.9) | 157.0 ± 6.8 (1.4–1.8) |
| Δ (%) | −2.6 | −1.7 |
| ES | 0.22 (trivial) | 0.48 (trivial) |
| BMI (kg/m2) | ||
| Pre | 26.6 ± 4.3 (16.6–39.7) | 28.8 ± 5.7 (20.3–43.4) |
| Post | 27.8 ± 4.3 (20.5–42.7) | 30.4 ± 5.8 (19–44.5) |
| Δ (%) | 7.0 | 10.4 |
| ES | −0.27 (trivial) | −0.27 (trivial) |
| Waist circumference (cm) | ||
| Pre | 92.5 ± 12.4 (63–124) | 100.5 ± 13.3 (72–133) |
| Post | 94.2 ± 10.7 (74–114) | 100.3 ± 19.4 (71–144) |
| Δ (%) | 3.6 | 1.6 |
| ES | −0.14 (trivial) | 0.01 (trivial) |
| Hip circumference (cm) | ||
| Pre | 102.5 ± 8.1 (88–120) | 107.6 ± 12.1 (89–141) |
| Post | 101.6 ± 10.3 (64–129) | 104.1 ± 18.1 (87–143) |
| Δ (%) | −0.1 | −1.8 |
| ES | 0.09 (trivial) | 0.22 (trivial) |
| Neck circumference (cm) | ||
| Pre | 35.4 ± 2.9 (30–45) | 36.8 ± 3.2 (30–44) |
| Post | 35.2 ± 5.5 (30–41) | 37.7 ± 8.4 (32–43) |
| Δ (%) | −0.2 | 3.2 |
| ES | 0.04 (trivial) | −0.14 (trivial) |
Data are presented as mean ± SD (min–max); NTS: normotensive; HTS: hypertensive; BMI: body mass index; ES: effect size (min–max).
Effect of MEP on functional parameters.
| Variable | NTS-OA | HTS-OA |
|---|---|---|
| Sit-to-stand (s) | ||
| Pre | 11.1 ± 3.4 (8–20.7) | 10.6 ± 2.6 (5–16.7) |
| Post | 10.8 ± 3.1 (6.3–20.5) | 10.4 ± 2.6 (5–16.9) |
| Δ (%) | −1.1 | 6.1 |
| ES | 0.09 (trivial) | 0.07 (trivial) |
| One-leg stand (s) | ||
| Pre | 18.3 ± 13.4 (0–30) | 15.6 ± 11.4 (0–30) |
| Post | 24.0 ± 8.3 (0–30) | 21.8 ± 9.1 (0–30) |
| Δ (%) | 101.9 | 107.5 |
| ES | −0.51 (small) | −0.60 (small) |
| Usual walking speed (m/s) | ||
| Pre | 0.82 ± 0.20 (0.5–1.7) | 0.90 ± 0.22 (0.5–1.7) |
| Post | 2.19 ± 0.50 (1.3–3.6) | 2.29 ± 0.60 (0.4–1.3) |
| Δ (%) | −7.8 | −10.6 |
| ES | 0.34 (trivial) | 0.69 (small) |
| Maximal walking speed (m/s) | ||
| Pre | 0.91 ± 0.30 (0.5–2) | 0.94 ± 0.30 (0.6–1.8) |
| Post | 1.73 ± 0.30 (1.2–2.5) | 1.74 ± 0.40 (1.2–1.8) |
| Δ (%) | −70.7 | 71.4 |
| ES | 2.75 (large) | 3.81 (large) |
| TUG (s) | ||
| Pre | 6.53 ± 1.52 (5.1–10.9) | 7.34 ± 1.26 (5.4–10.3) |
| Post | 6.86 ± 1.23 (5–10.9) | 7.05 ± 2.04 (5–13.6) |
| Δ (%) | 4.3 | −2.2 |
| ES | −0.23 (trivial) | 0.17 (trivial) |
| TUG with a cognitive task (s) | ||
| Pre | 7.41 ± 1.50 (4.7–12.6) | 8.30 ± 1.96 (5.7–16.9) |
| Post | 7.91 ± 1.69 (5–11.9) | 8.43 ± 2.57 (5–17.9) |
| Δ (%) | 11.0 | 4.8 |
| ES | −0.31 (trivial) | −0.05 (trivial) |
Data are presented as mean ± SD (min–max); NTS: normotensive; HTS: hypertensive; TUG: timed up and go; ES: effect size; P < 0.05 versus pre.
Effect of MEP on hemodynamic parameters.
| Variable | NTS-OA | HTS-OA |
|---|---|---|
| SBP (mmHg) | ||
| Pre | 127.6 ± 14.6 (96–162) | 135.6 ± 18.2 (99–181) |
| Post | 128.3 ± 17.8 (94–178) | 138.9 ± 20.9 (87–196) |
| Δ (%) | 2.2 | 2.0 |
| ES | −0.04 (trivial) | −0.16 (trivial) |
| DBP (mmHg) | ||
| Pre | 76.3 ± 9.7 (58–97) | 76.8 ± 11.9 (58–109) |
| Post | 73.8 ± 11.4 (49–113) | 78.0 ± 15.0 (59–149) |
| Δ (%) | −1.9 | 1.6 |
| ES | 0.23 (trivial) | −0.08 (trivial) |
| MAP (mmHg) | ||
| Pre | 89.2 ± 21.9 (73–114) | 94.7 ± 17.7 (78–123) |
| Post | 91.9 ± 12.5 (65–125) | 96.2 ± 20.4 (69–196) |
| Δ (%) | −0.3 | 1.2 |
| ES | −0.15 (trivial) | −0.07 (trivial) |
| HR (bpm) | ||
| Pre | 79.3 ± 10.0 (53–108) | 74.2 ± 11.3 (35–113) |
| Post | 79.6 ± 10.2 (51–102) | 78.6 ± 11.3 (58–130) |
| Δ (%) | 2.2 | 2.3 |
| ES | −0.02 (trivial) | −0.38 (trivial) |
| DP (mmHg·bpm) | ||
| Pre | 9693 ± 2906 (6625–17496) | 9930 ± 2587 (4270–14238) |
| Post | 10206 ± 1869 (4794–14596) | 10530 ± 3194 (6438–17640) |
| Δ (%) | 4.5 | 6.6 |
| ES | −0.20 (trivial) | −0.20 (trivial) |
| PP | ||
| Pre | 48.9 ± 16.7 (18–79) | 57.6 ± 17.8 (30–97) |
| Post | 54.3 ± 13.5 (18–81) | 59.6 ± 16.8 (27–99) |
| Δ (%) | 16.8 | 10.5 |
| ES | −0.35 (trivial) | −0.11 (trivial) |
Data are presented as mean ± SD (min–max); NTS: normotensive; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; HR: heart rate; DP: double product; PP: pulse pressure; P < 0.05 versus pre.